First and fatal case of autoimmune acquired factor XIII/13 deficiency after COVID-19/SARS-CoV-2 vaccination.

Shimoyama, Saori; Kanisawa, Yuji; Ono, Kento; Souri, Masayoshi; Ichinose, Akitada

Shimoyama, Saori; Kanisawa, Yuji; Ono, Kento; Souri, Masayoshi; Ichinose, Akitada.

Shimoyama S; Department of Hematology, Oji General Hospital, Tomakomai, Japan.
Kanisawa Y; Department of Hematology, Oji General Hospital, Tomakomai, Japan.
Ono K; Department of Hematology, Oji General Hospital, Tomakomai, Japan.
Souri M; Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan.
Ichinose A; The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies, Yamagata, Japan.

Am J Hematol ; 97(2): 243-245, 2022 02 01.

Article in English | MEDLINE | ID: covidwho-1544199

Subject(s)

BNT162 Vaccine/adverse effects; COVID-19/prevention & control; Factor XIII Deficiency/etiology; Aged; Autoimmune Diseases/etiology; Autoimmune Diseases/pathology; Factor XIII Deficiency/pathology; Female; Humans; SARS-CoV-2/isolation & purification; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Factor XIII Deficiency / COVID-19 / BNT162 Vaccine Type of study: Case report / Observational study Topics: Vaccines Limits: Aged / Female / Humans Language: English Journal: Am J Hematol Year: 2022 Document Type: Article Affiliation country: Ajh.26426

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google